The Effect of Repetitive Standardized Patient Simulation and End of Life Care Education on Nursing Students' Knowledge Attitudes and Moods

October 29, 2022 updated by: Betül Çakmak, Ankara Yildirim Beyazıt University

The Effects of End of Life Care Education and Repetitive Standard Patient-Based Simulation on Nursing Students' Knowledge Level, Attitudes and Moods Towards the Patient With Dying Process

This research is a randomized experimental intervention study designed to examine the effect of repetitive standard patient-based education given to nursing students with end-of-life care education nursing on the level of knowledge, attitudes, and moods of the patient's care during the death process.

Study Overview

Status

Completed

Conditions

Detailed Description

The research Sample of the study consisted of fourth-year nursing students who agreed to participate in the study (n=50). In the study, an end-of-life care nursing education program was applied to all students. In the second stage, the standard patient-based practice was performed once with the control group nursing students and twice with the intervention group students. In data collection, an end-of-life care nursing questionnaire, Frommelt attitude scale, positive-negative affect scale, and modified simulation effectiveness tool were used.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06010
        • Ankara Yıldırım Beyazıt University, Faculty of Health Sciences, Department of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Not having a course in which a four-year undergraduate education is unsuccessful,
  • Not participating in the pilot study of the research
  • To voluntarily agree to participate in the research.
  • Being a fourth-year student in the Department of Nursing

Exclusion Criteria:

  • Participating in the pilot study of the research
  • Wanting to leave the research.
  • Being a first, second and third-year student in the Department of Nursing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental: repetitive standardized patient simulation
In the study, an end-of-life care nursing education program was applied to all students. In the second stage, the standard patient-based practice was performed once with the control group nursing students and twice with the intervention group students.
In the study, an end-of-life care nursing education program was applied to all students. In the second stage, the standard patient-based practice was performed once with the control group nursing students and twice with the intervention group students. In data collection, an end-of-life care nursing questionnaire, Frommelt attitude scale, positive-negative affect scale, and modified simulation effectiveness tool were used.
No Intervention: control grup

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge level on end-of-life care nursing
Time Frame: 21 Days
Evaluated with an end-of-life care nursing questionnaire. This form was developed by the researcher. students answered the test exam. The exam consists of 25 questions. Minimum point is "0" and the maximum point is "100". The higher the score, the higher the knowledge level of the end of life care.
21 Days
Attitude score toward the care of the patient during the death process
Time Frame: 21 Days
Evaluated with the scale of Attitude Towards Caring for Dying Patients. Minimum point is "30" and the maximum point is "150". The higher the score, the higher the positive attitude.
21 Days
positive-negative mood level
Time Frame: 21 Days
Evaluated with Positive and negative affect:The PANAS Scales-PANAS. It includes 20 emotions, including 10 positive affect and 10 negative affect. It is evaluated in a 5-point Likert type and indicates that the emotion is felt as 1 = very little or not at all, 5 = very much.
21 Days
evaluate the effectiveness of the simulation environment
Time Frame: 21 Days
Evaluated with Simulation Effectiveness Tool-Modified. Minimum point is "18" and the maximum point is "95". The higher the score, the higher the positive perception of the learning activity.
21 Days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 26, 2022

Primary Completion (Actual)

March 19, 2022

Study Completion (Actual)

March 19, 2022

Study Registration Dates

First Submitted

October 24, 2022

First Submitted That Met QC Criteria

October 24, 2022

First Posted (Actual)

October 27, 2022

Study Record Updates

Last Update Posted (Actual)

November 2, 2022

Last Update Submitted That Met QC Criteria

October 29, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15.03.2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End of Life Care

Clinical Trials on repetitive standardized patient simulation

Subscribe